MSB 7.69% $1.19 mesoblast limited

Ann: Mesoblast Update on COVID-19 ARDS Trial, page-372

  1. 5,071 Posts.
    lightbulb Created with Sketch. 567
    someone might have already said,
    'DMSB recommended halting the trial." they said to continue with 233 already enrolled which suggest it has worked to a point, and that is what missing in this
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.